Proud Sponsor of the Organization of Women in International Trade - Badge

Antitrust Lawyer Blog

Executive Agrees to Go to Jail for Submitting Falsified Documents to the Antitrust Agencies During the Merger Review Process
Doyle, Barlow & Mazard PLLC

On May 3, 2012, the Antitrust Division of the Department of Justice (“DOJ”) announced that an executive of Hyosung Corporation, an affiliate of Nautilus Hyosung Holdings Inc. (“Nautilus”), agreed to plead guilty and serve five months in prison in the United States for obstruction of justice charges in connection with the antitrust agencies’ merger investigation…

Continue reading ›
FTC Closes Investigation of Express Script’s Proposed Acquisition of Medco
Doyle, Barlow & Mazard PLLC

On April 2, 2012, the Federal Trade Commission (“FTC”) closed its investigation of Express Scripts, Inc.’s (“Express Scripts”) proposed acquisition of pharmacy benefits manager (“PBM”), Medco Health Solutions, Inc. (“Medco”) Express Scripts consummated its acquisition of Medco on the same day.Background On July 20, 2011, Express Scripts entered into an agreement to acquire Medco for…

Continue reading ›
Humana Settles With DOJ Regarding Arcadian
Doyle, Barlow & Mazard PLLC

On March 27, 2012, the DOJ announced it would require Humana, a leading health insurer in the United States with 2010 revenues of approximately $33.6 billion, and Arcadian, which had approximately 62,000 MA members in 15 states and 2010 revenues of $622 million, to divest assets relating to Arcadian’s MA business in parts of five…

Continue reading ›
DOJ Requires Divestitures Allowing International Paper to Acquire Temple-Inland
Doyle, Barlow & Mazard PLLC

On February 10, 2012, the Department of Justice (“Department”) entered into a settlement that allows International Paper to acquire Temple-Inland. The settlement agreement requires International Paper and Temple-Inland Inc. to divest three containerboard mills in order to proceed with their $4.3 billion merger. The Department said that the merger, as originally proposed, would have substantially…

Continue reading ›
FTC to Revise Investigatory Rules, Attorney Disciplinary Rules
Doyle, Barlow & Mazard PLLC

On January 13, 2012, the FTC issued proposed amendments to Parts 2 and 4 of its Rules of Practice (“Rules”). Written comments must be received by March 23, 2012. The FTC first raised the need to reform Part 2 citing a substantial risk of delay and mistakes in the FTC’s discovery process based on the…

Continue reading ›
Promedica Health System Ordered to Divest St. Luke’s Hospital
Doyle, Barlow & Mazard PLLC

In an initial decision issued on January 5, 2012, FTC Chief Administrative Law Judge D. Michael Chappell ordered ProMedica Health System Inc to divest recently-acquired St. Luke’s Hospital to an FTC-approved buyer within 180 days after the order becomes final. See http://www.ftc.gov/os/adjpro/d9346/120105promedicadecision.pdfIn May 2010, in a non-HSR reportable transaction, ProMedica agreed with the FTC to…

Continue reading ›
China’s Ministry of Commerce Passes Measures on Unreported Transactions
Doyle, Barlow & Mazard PLLC

On December 30, 2011, China’s Ministry of Commerce (“MOFCOM”), the government agency tasked with merger review, formally promulgated new rules providing MOFCOM with clear procedural rules (and powers) to investigate and deal with reportable transactions that were not notified. These Provisional Measures on the Investigation and Treatment of Failure to Report Concentration of Undertakings (“Provisional…

Continue reading ›
FTC Settles With Pool Supplier Regarding Exclusive Dealing Practices
Doyle, Barlow & Mazard PLLC

On November 21, 2011, the Federal Trade Commission (“FTC”) settled allegations of violations of Section 5 of the Federal Trade Commission Act, 15 U.S.C. 45 (“FTC Act”) against Pool Corporation (“PoolCorp”). PoolCorp and the FTC reached a proposed consent agreement resolving charges that PoolCorp used exclusionary acts and practices to maintain its monopoly power in…

Continue reading ›
Aerial view of Washington DC cityscape from Arlington Virginia USA.

Contact Us

Fill out the form or call us at (202) 589-1834 to schedule your consultation.